Erschienen in:
01.10.2009 | Commentary
Terlipressin or Europressin?
verfasst von:
Marc Leone
Erschienen in:
Critical Care
|
Ausgabe 5/2009
Einloggen, um Zugang zu erhalten
Abstract
Use of terlipressin in septic shock relies on a series of European studies resulting in a better knowledge of this vasopressive agent. Additional studies demonstrate that this agent appears to have attractive properties when administered properly. In comparison to prior reports, continuous infusion of low-dose terlipressin seems superior when administered to septic animals. For the first time in humans, Morelli and colleagues compared this mode of administration with other vasopressors.